Articles with "daa era" as a keyword



Uptake of interferon‐free DAA therapy among HCV‐infected decompensated cirrhosis patients and evidence for decreased mortality

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Viral Hepatitis"

DOI: 10.1111/jvh.13543

Abstract: Interferon‐free DAA therapies have recently been licensed for patients infected with hepatitis C virus (HCV) who have decompensated cirrhosis (DC). Our aim was to describe factors associated with uptake of IFN‐free DAAs in DC patients… read more here.

Keywords: interferon free; daa; daa era; mortality ... See more keywords

The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Viral Hepatitis"

DOI: 10.1111/jvh.13665

Abstract: The recently reported epidemic of acute hepatitis C virus (HCV) infections —observed predominantly among men who have sex with men (MSM)—may now decline due to wide availability of direct‐acting antivirals (DAAs). This study aimed to… read more here.

Keywords: acute hepatitis; daa era; era;

Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era and the COVID‐19 pandemic

Sign Up to like & get
recommendations!
Published in 2024 at "Journal of Viral Hepatitis"

DOI: 10.1111/jvh.13983

Abstract: HCV infection poses a global health threat, with significant morbidity and mortality. This study examines HCV trends in a large Italian region from 2015 to 2022, considering demographic changes, evolving clinical profiles, treatment regimens and… read more here.

Keywords: epidemiology; treatment; covid pandemic; treatment outcomes ... See more keywords

Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience

Sign Up to like & get
recommendations!
Published in 2017 at "BMJ Open Gastroenterology"

DOI: 10.1136/bmjgast-2017-000181

Abstract: Background Cure rates for chronic hepatitis C have improved dramatically with direct-acting antivirals (DAAs), but treatment barriers remain. We aimed to compare treatment initiation rates and barriers across both interferon-based and DAA-based eras. Methods We… read more here.

Keywords: era; treatment; daa era; chronic hepatitis ... See more keywords